PALISADE CAPITAL MANAGEMENT, LP - VIROPHARMA INC ownership

VIROPHARMA INC's ticker is and the CUSIP is 928241AH1. A total of 29 filers reported holding VIROPHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of VIROPHARMA INC
ValueSharesWeighting
Q3 2013$19,744,000
+30.7%
9,202,0000.0%0.54%
+23.5%
Q2 2013$15,107,000
+30.2%
9,202,000
+18.7%
0.43%
+20.9%
Q1 2013$11,606,000
+22.6%
7,750,000
+14.8%
0.36%
+16.6%
Q4 2012$9,467,0006,750,0000.31%
Other shareholders
VIROPHARMA INC shareholders Q3 2013
NameSharesValueWeighting ↓
Sage Capital Management, LLC 3,300,000$7,072,0006.75%
SYMPHONY ASSET MANAGEMENT LLC 23,200,000$49,721,0005.04%
Mohican Financial Management, LLC 10,259,000$21,986,0005.01%
GRACE BROTHERS MANAGEMENT LLC 2,500,000$5,361,0004.56%
BASSO CAPITAL MANAGEMENT, L.P. 8,750,000$18,714,0003.27%
Bruce & Co., Inc. 2,000,000$4,000,0001.31%
TENOR CAPITAL MANAGEMENT Co., L.P. 6,000,000$12,872,0001.22%
Verition Fund Management LLC 2,500,000$5,370,0000.81%
Polar Asset Management Partners Inc. 7,500,000$16,078,0000.68%
WOLVERINE ASSET MANAGEMENT LLC 12,955,000$27,745,0000.62%
View complete list of VIROPHARMA INC shareholders